These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6234351)

  • 1. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
    Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
    J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
    Padberg WM; Kupiec-Weglinski JW; Lord RH; Araneda DH; Tilney NL
    J Immunol; 1987 Jun; 138(11):3669-74. PubMed ID: 2953786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells.
    Clason AE; Duarte AJ; Kupiec-Weglinski JW; Williams JN; Wang BS; Strom TB; Tilney NL
    J Immunol; 1982 Jul; 129(1):252-9. PubMed ID: 7045223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities.
    Whitby EH; Sparshott SM; Bell EB
    Immunology; 1990 Jan; 69(1):78-84. PubMed ID: 2138126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-graft relationship: the systemic nature of allograft rejection.
    Kupiec-Weglinski JW; Araujo JL; Towpik E; Araneda D; Tilney NL
    Surgery; 1985 Aug; 98(2):259-66. PubMed ID: 3895538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
    Padberg WM; Lord RH; Kupiec-Weglinski JW; Williams JM; Di Stefano R; Thornburg LE; Araneda D; Strom TB; Tilney NL
    J Immunol; 1987 Sep; 139(6):1751-7. PubMed ID: 2957435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
    Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
    Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
    Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL
    Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of rat B cell responses by T cell subsets and interleukin 2.
    Rosenberg JS; Gilman SC; Feldman JD
    J Immunol; 1982 Sep; 129(3):996-1001. PubMed ID: 6809819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell synergy in the primary MLR: proliferative kinetics, effector cell generation, and IL 2 production.
    Salomon DR; Cohen DJ; Williams JM; Carpenter CB
    J Immunol; 1984 Dec; 133(6):3075-83. PubMed ID: 6238093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
    Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
    J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat.
    Elder ME; Maclaren NK
    J Immunol; 1983 Apr; 130(4):1723-31. PubMed ID: 6220066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
    Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
    J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.